147 related articles for article (PubMed ID: 38230716)
1. Investigating the Factor Structure of the Preclinical Alzheimer Cognitive Composite and Cognitive Function Index across Racial/Ethnic, Sex, and Aβ Status Groups in the A4 Study.
Ruthirakuhan M; Wood Alexander M; Cogo-Moreira H; Robinson T; Amariglio R; Buckley RF; Sperling RA; Swardfager W; Black SE; Rabin JS
J Prev Alzheimers Dis; 2024; 11(1):48-55. PubMed ID: 38230716
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of the Preclinical Alzheimer's Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer's Disease -Atabecestat Phase 2b/3 EARLY Clinical Trial.
Papp KV; Rofael H; Veroff AE; Donohue MC; Wang S; Randolph C; Grober E; Brashear HR; Novak G; Ernstrom K; Raman R; Aisen PS; Sperling R; Romano G; Henley D
J Prev Alzheimers Dis; 2022; 9(2):255-261. PubMed ID: 35542998
[TBL] [Abstract][Full Text] [Related]
3. Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals.
Sperling RA; Donohue MC; Raman R; Sun CK; Yaari R; Holdridge K; Siemers E; Johnson KA; Aisen PS;
JAMA Neurol; 2020 Jun; 77(6):735-745. PubMed ID: 32250387
[TBL] [Abstract][Full Text] [Related]
4. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.
Donohue MC; Sperling RA; Salmon DP; Rentz DM; Raman R; Thomas RG; Weiner M; Aisen PS; ; ;
JAMA Neurol; 2014 Aug; 71(8):961-70. PubMed ID: 24886908
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.
Bransby L; Lim YY; Ames D; Fowler C; Roberston J; Harrington K; Snyder PJ; Villemagne VL; Salvado O; Masters CL; Maruff P
J Clin Exp Neuropsychol; 2019 Aug; 41(6):591-600. PubMed ID: 30924399
[No Abstract] [Full Text] [Related]
6. Measurement invariance of neuropsychological measures of cognitive aging across race/ethnicity by sex/gender groups.
Avila JF; Rentería MA; Witkiewitz K; Verney SP; Vonk JMJ; Manly JJ
Neuropsychology; 2020 Jan; 34(1):3-14. PubMed ID: 31464473
[TBL] [Abstract][Full Text] [Related]
7. Genetic Moderation of the Association of β-Amyloid With Cognition and MRI Brain Structure in Alzheimer Disease.
Insel PS; Kumar A; Hansson O; Mattsson-Carlgren N;
Neurology; 2023 Jul; 101(1):e20-e29. PubMed ID: 37085326
[TBL] [Abstract][Full Text] [Related]
8. Association of Alcohol Consumption with Cognition in Older Population: The A4 Study.
Nallapu BT; Petersen KK; Lipton RB; Grober E; Sperling RA; Ezzati A
J Alzheimers Dis; 2023; 93(4):1381-1393. PubMed ID: 37182868
[TBL] [Abstract][Full Text] [Related]
9. Sex Differences in the Associations of Obesity with Tau, Amyloid PET, and Cognitive Outcomes in Preclinical Alzheimer's Disease: Cross-Sectional A4 Study.
Wang X; Sundermann EE; Buckley RF; Reas ET; McEvoy LK; Banks SJ;
J Alzheimers Dis; 2023; 95(2):615-624. PubMed ID: 37574737
[TBL] [Abstract][Full Text] [Related]
10. The Computerized Cognitive Composite (C3) in an Alzheimer's Disease Secondary Prevention Trial.
Papp KV; Rentz DM; Maruff P; Sun CK; Raman R; Donohue MC; Schembri A; Stark C; Yassa MA; Wessels AM; Yaari R; Holdridge KC; Aisen PS; Sperling RA
J Prev Alzheimers Dis; 2021; 8(1):59-67. PubMed ID: 33336226
[TBL] [Abstract][Full Text] [Related]
11. Subjective cognitive decline across ethnoracial groups in the A4 study.
Robinson T; Klinger H; Buckley R; Deters KD; Quiroz YT; Rentz D; Rabin JS; Sperling RA; Amariglio RE
Alzheimers Dement; 2023 Sep; 19(9):4084-4093. PubMed ID: 37218387
[TBL] [Abstract][Full Text] [Related]
12. Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial.
Raman R; Quiroz YT; Langford O; Choi J; Ritchie M; Baumgartner M; Rentz D; Aggarwal NT; Aisen P; Sperling R; Grill JD
JAMA Netw Open; 2021 Jul; 4(7):e2114364. PubMed ID: 34228129
[TBL] [Abstract][Full Text] [Related]
13. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
Insel PS; Hansson O; Mattsson-Carlgren N
JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
[TBL] [Abstract][Full Text] [Related]
14. Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β.
Mormino EC; Papp KV; Rentz DM; Donohue MC; Amariglio R; Quiroz YT; Chhatwal J; Marshall GA; Donovan N; Jackson J; Gatchel JR; Hanseeuw BJ; Schultz AP; Aisen PS; Johnson KA; Sperling RA
Alzheimers Dement; 2017 Sep; 13(9):1004-1012. PubMed ID: 28253478
[TBL] [Abstract][Full Text] [Related]
15. Association of Short and Long Sleep Duration With Amyloid-β Burden and Cognition in Aging.
Winer JR; Deters KD; Kennedy G; Jin M; Goldstein-Piekarski A; Poston KL; Mormino EC
JAMA Neurol; 2021 Oct; 78(10):1187-1196. PubMed ID: 34459862
[TBL] [Abstract][Full Text] [Related]
16. Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial.
Molina-Henry DP; Raman R; Liu A; Langford O; Johnson K; Shum LK; Glover CM; Dhadda S; Irizarry M; Jimenez-Maggiora G; Braunstein JB; Yarasheski K; Venkatesh V; West T; Verghese PB; Rissman RA; Aisen P; Grill JD; Sperling RA
Alzheimers Dement; 2024 Jun; 20(6):3827-3838. PubMed ID: 38629508
[TBL] [Abstract][Full Text] [Related]
17. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
[TBL] [Abstract][Full Text] [Related]
18. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
[TBL] [Abstract][Full Text] [Related]
20. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
